From: Metabolomics in severe traumatic brain injury: a scoping review
Metabolite | Sample type | Change identified | Supplemental | Refs. |
---|---|---|---|---|
Octanoic acid | ||||
Serum/Plasma | Increase | Increased as TBI severity increased | Thomas et al. [32] | |
Serum/Microdialysate | Increase | Found upregulated in sTBI patients and remained high in most patients | Oresic et al. [33] | |
Decanoic acid | ||||
Serum/Plasma | Increase | Increased as TBI severity increased | Thomas et al. [32] | |
Serum/Microdialysate | Increase | Found upregulated in sTBI patients and remained high in most patients | Oresic et al. [33] | |
Serine | ||||
Serum/Microdialysate | Decrease | Found downregulated in all TBIs and more strongly in sTBI | Oresic et al. [33] | |
Serum/Plasma | Decrease | Found decreased in all TBI patients overall | Thomas et al. [32] | |
Serum/Plasma | Decrease | ≤ 60% the concentration in jugular blood compared to HC | Wolahan et al. [34] | |
Inositol/Myo-inositol | ||||
Inositol | Serum/Microdialysate | Increase | Found to increase in patients with detectable pathology on a CT scan or the presence of a mass lesion following TBI | Dickens et al. [36] |
Myo-inositol | Serum/Plasma | Increase | Found elevated in TBI patients and proportional to differing severity | Thomas et al. [32] |
Alanine | ||||
Serum/Microdialysate | Decrease | Found downregulated in all TBIs and more strongly in sTBI | Oresic et al. [33] | |
Serum/Plasma | Decrease | Found decreased in TBI patients overall | Thomas et al. [32] | |
Choline | ||||
Serum/Plasma | Decrease | Significantly reduced in sTBI compared to mTBI and healthy volunteers | Dash et al. [29] | |
Serum/Plasma | Increase | Net cerebral release or increase in jugular venous blood | Wolahan et al. [34] | |
MR imaging | Increase | Decrease in patients with differing degrees of TBI, including sTBI | Marino et al. [25] | |
Lactate | ||||
CSF | Increase | A slight statistically increasing trend in sTBI patients compared to non-injured controls | Glenn et al. [37] | |
MR Imaging | Increase | Diffusely high signal of lactate resonance intensity in patients with acute TBI including sTBI | Marino et al. [25] | |
CSF | Increase | Significantly increased compared to control and survival groups | Stefani et al. [38] | |
Citrulline | ||||
Serum/Plasma | Decrease | ≤ 60% the concentration in jugular blood compared to HC | Wolahan et al. [34] | |
Serum/Plasma | Decrease | Significantly reduced in the plasma of sTBI patients | Jeter et al. [26] | |
Proline and derivatives | ||||
Proline | Serum/Plasma | Decrease | ≤ 60% the concentration in arterial plasma compared to HC | Wolahan et al. [34] |
Proline | Serum/Plasma | Decrease | Significantly reduced in the plasma of sTBI patients compared to healthy volunteers, orthopedic controls, and mTBI patients | Jeter et al. [26] |
5-oxoproline | Serum/Plasma | Decrease | Significantly reduced in sTBI patients compared to mTBI and healthy volunteers | Dash et al. [29] |
Hydroxyproline | Serum/Plasma | Decrease | Significantly reduced in the plasma of sTBI patients compared to healthy volunteers, orthopedic controls, and mTBI patients | Jeter et al. [26] |
Hydroxyproline | Serum/Plasma | Decrease | ≤ 60% the concentration in jugular blood compared to HC | Wolahan et al. [34] |
Methionine | ||||
Urine | Increase | Significant negative correlation (increase) to patients decreasing GCS scores | Bykowski et al. [30] | |
Serum/Plasma | Decrease | Significant reduction in plasma relative to healthy volunteers | Dash et al. [29] | |
Xanthine | ||||
Serum/Plasma | Increase | Significant net cerebral release/increase in jugular venous blood | Wolahan et al. [34] | |
Urine | Increase | Increased levels following recovery | Bykowski et al. [30] | |
N-acetylaspartate | ||||
Microdialysate | Decrease | Steep decline of extracellular NAA seen in 8 patients early on | Shannon et al. [28] | |
MR Imaging | Decrease | Decrease in patients with differing degrees of TBI, including sTBI | Marino et al. [25] | |
2/3-hydroxybutryic acid | ||||
2-hydroxybutyrate | Serum/Plasma | Increase | Found significantly increased in sTBI patients | Dash et al. [29] |
2-hydroxybutyric acid | Serum/Microdialysate | Increase | Found upregulated in sTBI patients | Oresic et al. [33] |
3-hydroxybutyric acid | Serum/Microdialysate | Increase | Found upregulated in sTBI patients | Oresic et al. [33] |
Valine | ||||
Serum/Plasma | Decrease | Reduction in levels detected in the plasma of sTBI patients compared to all other groups | Jeter et al. [27] | |
Serum/Plasma | Decrease | Significantly decreased during the first week post Stbi compared to controls | Vuille-Dit-Bille [35] | |
Leucine | ||||
Serum/Plasma | Decrease | Decrease in patients with sTBI compared to healthy volunteers and mTBI patients | Jeter et al. [27] | |
Serum/Plasma | Decrease | Significantly decreased during the first week post sTBI compared to controls | Vuille-Dit-Bille [35] |